slides · global inventory
Paragraph
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 118,578
Current window 101,701-101,730
Pages 3,953
Rows per page 30
Component
101,701-101,730 of 118,578
55
The slide uses a map of the world with EMEA highlighted (implied by context).Hugo Boss | Investor Presentation Deck | 99 slides · Hugo Boss
Conference presentation Investor relations 1 hit
63
The slide uses a numbered list format to present the five pillars.Hugo Boss | Investor Presentation Deck | 99 slides · Hugo Boss
Conference presentation Investor relations 1 hit
77
The slide uses a simple bar chart representation to show growth from 4.2B EUR in 2023 to a range of 4.30-4.45B EUR in 2024.Hugo Boss | Investor Presentation Deck | 99 slides · Hugo Boss
Conference presentation Investor relations Beat · Financials1 hit
80
The slide uses a bar chart metaphor to show growth from 2023 to 2024.Hugo Boss | Investor Presentation Deck | 99 slides · Hugo Boss
Conference presentation Investor relations 1 hit
85
Hugo Boss | Investor Presentation Deck | 99 slidesHugo Boss | Investor Presentation Deck | 99 slides · Hugo Boss
Conference presentation Investor relations 1 hit
94
Includes photos of employees holding pictures of themselves as children.Hugo Boss | Investor Presentation Deck | 99 slides · Hugo Boss
Conference presentation Investor relations 1 hit
95
The slide uses a comparison table structure to contrast STI and LTI components.Hugo Boss | Investor Presentation Deck | 99 slides · Hugo Boss
Conference presentation Investor relations 1 hit
03
The slide features a portrait of the CEO and the company logo.Hugo Boss | Results Presentation Deck | 44 slides · Hugo Boss
Conference presentation Investor relations Beat · Attention1 hit
05
The slide outlines the core strategic pillars: 1. Boost Brands, 2. Product is Key, 3. Lead in Digital, 4. Drive Omnichannel, 5. Organize for Growth.Hugo Boss | Results Presentation Deck | 44 slides · Hugo Boss
Conference presentation Investor relations Beat · NeedLoop · Golden Circle1 hit
07
The slide uses a numbered list structure to represent strategic pillars under the 'Consumer First' umbrella.Hugo Boss | Results Presentation Deck | 44 slides · Hugo Boss
Conference presentation Investor relations Beat · Need1 hit
12
The slide uses a numbered list of five strategic pillars, with the second pillar highlighted.Hugo Boss | Results Presentation Deck | 44 slides · Hugo Boss
Conference presentation Investor relations 1 hit
16
The slide uses a split-screen layout with a black background for the rollout timeline and a photo background for the productivity metric.Hugo Boss | Results Presentation Deck | 44 slides · Hugo Boss
Conference presentation Investor relations 1 hit
19
The slide visualizes the 'CLAIM 5' strategy framework.Hugo Boss | Results Presentation Deck | 44 slides · Hugo Boss
Conference presentation Investor relations 1 hit
20
The slide uses a gradient bar chart to represent values and a large metric for employee satisfaction.Hugo Boss | Results Presentation Deck | 44 slides · Hugo Boss
Conference presentation Investor relations 1 hit
23
Hugo Boss | Results Presentation Deck | 44 slidesHugo Boss | Results Presentation Deck | 44 slides · Hugo Boss
Conference presentation Investor relations 1 hit
33
Hugo Boss | Results Presentation Deck | 44 slidesHugo Boss | Results Presentation Deck | 44 slides · Hugo Boss
Conference presentation Investor relations Beat · Action1 hit
34
The slide uses a simple bar chart comparison between 2023 actuals and 2024 estimates.Hugo Boss | Results Presentation Deck | 44 slides · Hugo Boss
Conference presentation Investor relations Beat · Action1 hit
37
The slide uses a simple bar chart visualization to compare 2023 actuals with 2024 estimates.Hugo Boss | Results Presentation Deck | 44 slides · Hugo Boss
Conference presentation Investor relations Beat · Action1 hit
43
Hugo Boss | Results Presentation Deck | 44 slidesHugo Boss | Results Presentation Deck | 44 slides · Hugo Boss
Conference presentation Investor relations Beat · Action1 hit
05
The slide uses a Gantt-style chart to represent clinical trial stages.Immix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
07
The slide uses a structural diagram to map technical modifications to clinical outcomes.Immix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations Beat · Solution1 hit
13
Uses a bar chart to compare CRS duration in days across four competitors, with NXC-201 highlighted as significantly lower.Immix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
18
N-GENIUS TECHNOLOGY PLATFORM; NEXICART-1 Clinical Trial Data.Immix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
21
Uses a combination of bar charts for preclinical data and a comparison table for clinical outcomes to demonstrate the superiority of the CD8 hinge optimization.Immix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
29
The table compares NXC-201 against Darzalex, CAEL-101, and Birtamimab across various clinical metrics.Immix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
31
The slide uses a structural layout to map platform capabilities to specific therapeutic products.Immix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
34
Includes a comparative table of clinical outcomes (ORR, CR/sCR) for NXC-201 vs competitors.Immix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
46
Includes three distinct proof-of-concept data panels (penetration, biodistribution, apoptosis).Immix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
53
Includes a comparison of iMX-111 size vs IgG antibody, GLUT1 expression across tissues, correlation with cancer stage, and a survival curve.Immix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
54
The slide uses a combination of mechanism diagrams, clinical trial bar charts, and preclinical mouse model data to validate the therapeutic approach.Immix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations 1 hit